Mukund Kakani Acquires Convertible Warrants in Godavari Drugs Ltd.
Godavari Drugs Limited announced that Mukund Kakani, a promoter of the company, has acquired 4,69,000 convertible warrants through a preferential issue on March 18, 2026.According to a regulatory filing, Kakani’s acquisition was made by way of preferential allotment. The total share capital of Godavari Drugs Limited stands at Rs. 7,53,05,000, divided into 75,30,500 fully paid-up equity shares of Rs. 10 each. Following the acquisition, the equity share capital of the company is Rs. 10,12,74,350, comprised of 1,01,27,430 equity shares of Rs. 10 each. The total diluted share/voting capital of the company now stands at Rs. 12,48,75,000, divided into 1,24,87,500 fully paid-up equity shares of Rs. 10 each.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.